Growing worldwide prevalence of atopic dermatitis, allergic contact dermatitis and urticaria is expected to drive market growth during the forecast period.
For More Information Visit - http://www.grandviewresearch.com/industry-analysis/pruritus-therapeutics-market
Europe In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Gene...ReportsnReports
This report provides an in-depth analysis of the in vitro diagnostics market in Europe from 2004-2018. It examines market size and revenue for major categories like clinical chemistry, genetic testing, and hematology in countries like Germany, France, UK, Italy and Spain. The 445-page report includes historical data from 2004-2011, forecasts to 2018, and profiles of key companies in the market. It provides a comprehensive overview of market drivers, trends and opportunities for businesses in the European in vitro diagnostics space.
The document discusses the global antifungal drugs market. It provides an analysis of the market by region, including North America, Europe, Asia Pacific, and the rest of the world. It also analyzes the market by country and by drug class and therapeutic indications. The market is segmented by drug class into azoles, echinocandins, polyenes, and others. The therapeutic indications covered are candidiasis, aspergillosis, dermatophytosis, and others. The market is forecast to grow steadily between 2013-2023 driven by increasing fungal infections globally.
M&A in pharmaceutical industry between india and italyVishal Singh
This document provides an overview of the pharmaceutical markets in India and Italy. It begins with a summary of the global pharmaceutical market, noting that it grew to $1,324 billion in 2018, with North America making up 48% of the market. India's population growth and rising incomes are making it an attractive emerging market. The pharmaceutical market in India is divided between domestic and export markets. The revenues and lower costs of the Indian pharmaceutical industry make it competitive globally. The document then shifts to provide context on the Italian pharmaceutical market before comparing the two.
"The Global In Vitro Diagnostics (IVD) Market is calculated to reach $91.49 billion by 2024, at a CAGR of
6.01% during the forecast period 2019-2024. The rising demand for early and accurate disease diagnosis, increasing adoption of fully-automated instruments and automation in laboratories,
increasing adoption of point-of-care testing, and growing awareness of personalized medicine are the
key factors driving the growth of the market."
The top 10 advanced materials & technologies in electronics refers to the new or modifications to the existing materials & technologies to obtain superior performance or efficiency. The market for top 10 advanced materials & technologies in electronics is witnessing high growth owing to the increasing end-use applications, technological advances, and the high demand of these technologies from both the developed and emerging regions.
Global Alzheimer's Drug Market Trends Opportunities and Forecasts (2015-2020)AzothAnalytics
The brochure of the report comprises of various dynamics of the Global Alzheimer's Drug Market:
The report includes an in depth analysis of:
Market Size and Share:By Type,Region,Age Group
This document summarizes the key findings of a report on the global vaccine market forecast from 2012 to 2017. It includes an analysis of major vaccines currently on the market and in development pipelines, as well as the competitive landscape and market potential in key geographical regions such as the US, Europe, India, and China. The report methodology involved extensive secondary and primary research on vaccine manufacturers, industry reports, clinical studies and government databases to analyze market trends, size, growth opportunities and challenges in the global vaccine industry.
Global Anti-Pollution Mask Market: Opportunities and Forecast (2017-2022)AzothAnalytics
The document discusses the global anti-pollution mask market from 2012-2022. It covers the market size by value and volume, breakdown by type, filter, distribution channel, and region/country. The market is segmented by disposable and reusable masks, N95, N99 and other filters, and online and offline distribution. Market drivers include increasing pollution levels, health awareness, and expanding middle class populations in Asia. Key regions analyzed are North America, Europe, Asia Pacific, and Rest of World. Major countries covered include the US, UK, France, China, India, Japan, Brazil and Saudi Arabia. Leading companies in the anti-pollution mask industry are also profiled.
Europe In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Gene...ReportsnReports
This report provides an in-depth analysis of the in vitro diagnostics market in Europe from 2004-2018. It examines market size and revenue for major categories like clinical chemistry, genetic testing, and hematology in countries like Germany, France, UK, Italy and Spain. The 445-page report includes historical data from 2004-2011, forecasts to 2018, and profiles of key companies in the market. It provides a comprehensive overview of market drivers, trends and opportunities for businesses in the European in vitro diagnostics space.
The document discusses the global antifungal drugs market. It provides an analysis of the market by region, including North America, Europe, Asia Pacific, and the rest of the world. It also analyzes the market by country and by drug class and therapeutic indications. The market is segmented by drug class into azoles, echinocandins, polyenes, and others. The therapeutic indications covered are candidiasis, aspergillosis, dermatophytosis, and others. The market is forecast to grow steadily between 2013-2023 driven by increasing fungal infections globally.
M&A in pharmaceutical industry between india and italyVishal Singh
This document provides an overview of the pharmaceutical markets in India and Italy. It begins with a summary of the global pharmaceutical market, noting that it grew to $1,324 billion in 2018, with North America making up 48% of the market. India's population growth and rising incomes are making it an attractive emerging market. The pharmaceutical market in India is divided between domestic and export markets. The revenues and lower costs of the Indian pharmaceutical industry make it competitive globally. The document then shifts to provide context on the Italian pharmaceutical market before comparing the two.
"The Global In Vitro Diagnostics (IVD) Market is calculated to reach $91.49 billion by 2024, at a CAGR of
6.01% during the forecast period 2019-2024. The rising demand for early and accurate disease diagnosis, increasing adoption of fully-automated instruments and automation in laboratories,
increasing adoption of point-of-care testing, and growing awareness of personalized medicine are the
key factors driving the growth of the market."
The top 10 advanced materials & technologies in electronics refers to the new or modifications to the existing materials & technologies to obtain superior performance or efficiency. The market for top 10 advanced materials & technologies in electronics is witnessing high growth owing to the increasing end-use applications, technological advances, and the high demand of these technologies from both the developed and emerging regions.
Global Alzheimer's Drug Market Trends Opportunities and Forecasts (2015-2020)AzothAnalytics
The brochure of the report comprises of various dynamics of the Global Alzheimer's Drug Market:
The report includes an in depth analysis of:
Market Size and Share:By Type,Region,Age Group
This document summarizes the key findings of a report on the global vaccine market forecast from 2012 to 2017. It includes an analysis of major vaccines currently on the market and in development pipelines, as well as the competitive landscape and market potential in key geographical regions such as the US, Europe, India, and China. The report methodology involved extensive secondary and primary research on vaccine manufacturers, industry reports, clinical studies and government databases to analyze market trends, size, growth opportunities and challenges in the global vaccine industry.
Global Anti-Pollution Mask Market: Opportunities and Forecast (2017-2022)AzothAnalytics
The document discusses the global anti-pollution mask market from 2012-2022. It covers the market size by value and volume, breakdown by type, filter, distribution channel, and region/country. The market is segmented by disposable and reusable masks, N95, N99 and other filters, and online and offline distribution. Market drivers include increasing pollution levels, health awareness, and expanding middle class populations in Asia. Key regions analyzed are North America, Europe, Asia Pacific, and Rest of World. Major countries covered include the US, UK, France, China, India, Japan, Brazil and Saudi Arabia. Leading companies in the anti-pollution mask industry are also profiled.
The pharmaceutical industry in Europe is expected to grow at an annual rate of 3.2% from 2015-2022, driven by new innovations emerging across therapy areas like oncology and immunology. While oncology drugs will account for much of the growth, the top-selling drug in Europe in 2022 is predicted to be Xarelto rather than a cancer drug. Five of the top 10 drugs will treat cancer. However, funding all these new high-cost therapies may challenge healthcare systems. Pharmaceutical companies and payers will need to collaborate more closely on new funding models to support continued innovation.
The document discusses the present and future of the vaccine industry. It provides an overview of key topics like growth drivers, challenges, SWOT analysis and future developments. The vaccine industry is growing at 10-13% annually and will be valued at $1.4-1.8 billion in India by 2020. New vaccines are being developed for diseases like dengue, malaria and tuberculosis. Adjuvants and conjugate vaccines may help increase efficacy for elderly populations. Future areas of focus include adult vaccines, novel delivery methods, and harnessing new technologies.
This document discusses the state of the biosimilars market and provides insights from a conference on biosimilars. It finds that while biosimilars were initially expected to capture more of the market, positive developments are emerging. Biosimilar approvals and guidelines in regions like Europe and the US could help unlock the market's potential. However, regulatory frameworks remain fragmented globally and biosimilar adoption varies across therapies, countries, and regions. Emerging markets in particular represent opportunities for future biosimilar growth to expand access to biologics.
This document discusses the evolving global biosimilars landscape and opportunities. It notes that after slow initial growth, biosimilars are poised for accelerated growth over the next decade due to expiring biologic drug patents, new US legislation, and payer pressure to reduce costs. By 2015, biosimilars sales are projected to reach $1.9-2.6 billion, up significantly from 2011 levels. Key drivers include major biologics like Herceptin, Enbrel and Humalog losing patent protection and increased focus on areas like oncology, diabetes and rheumatoid arthritis. A diverse range of competitors from generic drugmakers to large biopharmaceutical companies are pursuing biosimilar programs. However, realization of
Global cosmetic chemicals market forecast and opportunities, 2022 brochureKaleem
Global Cosmetic Chemicals Market By Type (Emollients & Moisturizers, Surfactant, etc.), By Application (Skin Care, Hair Care, etc.), By Region (Europe, Asia-Pacific, North America, South America & MEA), Competition Forecast & Opportunities, 2012–2022
Migraine Pipeline Drugs Market Assessment– Forecast to 2022AzothAnalytics
The report presents the market potential of seven major pipeline drugs meant for the treatment of migraine. These seven drugs that fall in the various categories of Ergotamines, Anti 5-HT Receptor Agonists and Anti-CGRPs by mechanism of action have been recognized as being clinically effective in migraine treatment. Expected to be launched in the market within the next 4-5 years, these seven potential drugs are likely to bring about major changes in the way migraine is treated globally.
Allergic Conjunctivitis, Global Market Analysis, Insights, and Forecast, 2021...Thuyamani M
- The global allergic conjunctivitis market was valued at $2.4 billion in 2020 and is projected to reach $3.6 billion by 2028, growing at a CAGR of 5.4%.
- Antihistamine & mast cell stabilizers accounted for the largest share of the market by drug class in 2020.
- North America accounted for 48% of the global market in 2020, with the US market valued at $1.16 billion that year.
- Recent advancements in allergic conjunctivitis therapeutics R&D are expected to drive market growth going forward.
The global blood preparation market is expected to reach $58.69 billion by 2022, driven by growing demand for blood transfusions and rising prevalence of blood-related disorders. Key factors fueling market growth include an increasing elderly population, commercialization of drugs in the product pipeline, and presence of advanced technologies for blood preparation and storage. The market is segmented by product, anti-thrombotic/anticoagulant type, and application. By product, plasma and blood components represent the largest segments. Geographically, North America accounts for the largest share currently but Asia Pacific is expected to experience the fastest growth over the forecast period.
The biocides market is expected to reach $14.81 billion by 2028, growing at a CAGR of 3.8% from 2021 to 2028. The market is segmented by product, application, and region. Key products include halogen compounds, metallic compounds, organosulfur compounds, and others. Main applications are water treatment, food and beverages, personal care, and others. Regionally, North America currently holds the largest market share, though Asia Pacific is expected to grow the fastest. The report also analyzes the impact of COVID-19 on the biocides market. Major players in the market include Troy Corporation, ChemTreat, Inc., Neogen Corporation, and others.
Medical Nonwoven Disposables Market Analysis, Size, Share, Growth To 2020 by...Grand View Research
Rapidly growing geriatric population base is another high impact rendering driver for the medical nonwoven disposables market as aging is considered as one of the greatest risk factor for the development of incontinence
For More Information Visit - http://www.grandviewresearch.com/industry-analysis/medical-nonwoven-disposables-market
Antibody market size to maintain the average annual growth rate of 12.69% from 5800 million $ in 2014 to 8300 million $ in 2017, Research analysts believe that in the next few years, Antibody market size will be further expanded, we expect that by 2022 , the market size of the Antibody will reach 14913 million $.
For More Details Visit: https://www.indexmarketsresearch.com/report/global-antibody-market-5/90056/
The edible Insect Market size is projected to reach USD 645.2 Million units by 2027 from an estimated USD 355.3 Million unit in 2019, growing at a CAGR of 22.4% globally.
"The Global Biostimulants Market is calculated to reach $4.61 billion by 2024. It is calculated to grow
with the CAGR of 11.12% during the forecast period 2019-2024. The organic food industry, which is
growing at a healthy rate, is the major driving force behind the growth of the biostimulant industry.
Increased awareness among the farmers about the benefits of biostimulants, is another factor
augmenting the growth of the market studied."
https://www.globalmarketstudies.com/product/biostimulants-market-report/
Gastrointestinal Pharmaceuticals: Technologies and MarketsReportLinker.com
Overall sales in the gastrointestinal disorder treatment market amounted to $34.2 billionin 2007, and decreased slightly to $31.1 billion in 2009. By 2014, they are projected to reach $32.2 billion, for a 5-year compound annual growth rate (CAGR) of 0.7%.The largest segment of the market, prescription gastrointestinal drugs, was valued at $27.4 billion in 2008; this is expected to decrease to $26,3 billion in 2009, and to reach $27 billion in 2014, for a 5-year CAGR of 0.5%.
Diabetic Retinopathy Market Analysis, Size, Segment To 2022 by Grand View Res...Grand View Research
Diabetic retinopathy is considered as a serious sight threatening complication that results due to long term diabetes.
For More Information Visit - http://www.grandviewresearch.com/industry-analysis/diabetic-retinopathy-market
INTRODUCTIONSTUDY GOALS AND OBJECTIVESBCC's goal in conducting this study was to understand the current status of the U.S. dermatological therapeutics industry and to assess it in the medium term from 2008 through 2013. We were particularly interested in understanding the future market potential for the current and emerging technologies and products within the dermatological therapeutics industry. This report assesses the available therapeutic procedures for skin, along with the drugs and technologies currently being used for various skin treatments. The role of public agencies, the regulatory environment, and non-governmental stakeholders has also been examined.REASONS FOR DOING THIS STUDYSkin disorders have a high active as well as passive morbidity in most human populations across the world. Yet, most dermatology manufacturers and dermatologists rely on cosmetic applications and procedures for survival.INTENDED AUDIENCEThis study is likely to be of interest to individuals and organizations involved in aspects of dermatological therapeutics industry, such as research, manufacturing and even large buyers in the industry. This report will also be of interest to manufacturers and marketers of dermatological therapeutics industry across the world.
Aminoglycosides Market Analysis By Drug, Mode of Administration, Application...Grand View Research
Aminoglycosides Market Analysis By Drug (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin), By Mode of Administration (Feed, Injectables (Parenteral), Intra-mammary, Topical, Oral), By Application (Veterinary, Skin, Respiratory, UTI & Pelvic Disease, Neonatal Sepsis) And Segment Forecasts To 2022
The document discusses the global anti-counterfeit packaging market from 2012-2020. It provides an overview of key drivers, restraints, and trends in the market. The market was valued at $57.4 billion in 2013 and is projected to reach $142.7 billion by 2020. The report analyzes the market by technology, application, and geography. It also profiles major companies in the market like Alien Technology Corp, AlpVision, and Zebra Technologies Corp.
Medical gases are gases that find indirect or direct applications in the healthcare industry and medical gas equipment are referred to the equipment utilized for the production of medical gases. Furthermore, medical gases are either directly administered to patients or are used in medical procedures mainly as coolants and sterilants.
The global allantoin market is expected to reach $641.7 million by 2022, growing at a CAGR of 5.2% from 2016 to 2022. Growing demand from the pharmaceutical and cosmetics industries is driving market growth. Cosmetics accounted for 33.7% of the market in 2014 due to allantoin's moisturizing and skin-softening properties. The Asia-Pacific region is expected to experience the fastest growth due to increasing demand from China and India. Key players are expanding production capacity to meet rising demand for allantoin.
The Canadian dermatological therapeutics market size stood at around USD 1.65 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The Canadian skincare industry is growing tremendously at xx% from 2015-2019 and is forecasted to grow by xx% (2020-2028), as more Canadians are investing in their skincare and the market is driven by an aging population looking for solutions to maintaining healthy skin and younger. Technological advancements and the increasing prevalence of skincare are anticipated to fuel the growth.
Market Drivers
Canada’s market is majorly driven by the rising burden of dermatology diseases. The skincare market is driven by the consumer attitude that is, to improve their quality of life in terms of looks and this attitude is visible across all the age groups. The Growing demand for anti-aging products and innovative and eco-friendly packaging designs are attributing to the market growth in the country. Canada’s skin allergy market is forecasted to grow by 3.9% over the 2020-2027 period. The extensive presence of online retail channels is also influencing sales of cosmetics in the country. The collective incidence of dermatological diseases and increasing levels of awareness-related disease progression, Etiology, and available therapies are leading to the high growth of dermatological therapeutics.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
The pharmaceutical industry in Europe is expected to grow at an annual rate of 3.2% from 2015-2022, driven by new innovations emerging across therapy areas like oncology and immunology. While oncology drugs will account for much of the growth, the top-selling drug in Europe in 2022 is predicted to be Xarelto rather than a cancer drug. Five of the top 10 drugs will treat cancer. However, funding all these new high-cost therapies may challenge healthcare systems. Pharmaceutical companies and payers will need to collaborate more closely on new funding models to support continued innovation.
The document discusses the present and future of the vaccine industry. It provides an overview of key topics like growth drivers, challenges, SWOT analysis and future developments. The vaccine industry is growing at 10-13% annually and will be valued at $1.4-1.8 billion in India by 2020. New vaccines are being developed for diseases like dengue, malaria and tuberculosis. Adjuvants and conjugate vaccines may help increase efficacy for elderly populations. Future areas of focus include adult vaccines, novel delivery methods, and harnessing new technologies.
This document discusses the state of the biosimilars market and provides insights from a conference on biosimilars. It finds that while biosimilars were initially expected to capture more of the market, positive developments are emerging. Biosimilar approvals and guidelines in regions like Europe and the US could help unlock the market's potential. However, regulatory frameworks remain fragmented globally and biosimilar adoption varies across therapies, countries, and regions. Emerging markets in particular represent opportunities for future biosimilar growth to expand access to biologics.
This document discusses the evolving global biosimilars landscape and opportunities. It notes that after slow initial growth, biosimilars are poised for accelerated growth over the next decade due to expiring biologic drug patents, new US legislation, and payer pressure to reduce costs. By 2015, biosimilars sales are projected to reach $1.9-2.6 billion, up significantly from 2011 levels. Key drivers include major biologics like Herceptin, Enbrel and Humalog losing patent protection and increased focus on areas like oncology, diabetes and rheumatoid arthritis. A diverse range of competitors from generic drugmakers to large biopharmaceutical companies are pursuing biosimilar programs. However, realization of
Global cosmetic chemicals market forecast and opportunities, 2022 brochureKaleem
Global Cosmetic Chemicals Market By Type (Emollients & Moisturizers, Surfactant, etc.), By Application (Skin Care, Hair Care, etc.), By Region (Europe, Asia-Pacific, North America, South America & MEA), Competition Forecast & Opportunities, 2012–2022
Migraine Pipeline Drugs Market Assessment– Forecast to 2022AzothAnalytics
The report presents the market potential of seven major pipeline drugs meant for the treatment of migraine. These seven drugs that fall in the various categories of Ergotamines, Anti 5-HT Receptor Agonists and Anti-CGRPs by mechanism of action have been recognized as being clinically effective in migraine treatment. Expected to be launched in the market within the next 4-5 years, these seven potential drugs are likely to bring about major changes in the way migraine is treated globally.
Allergic Conjunctivitis, Global Market Analysis, Insights, and Forecast, 2021...Thuyamani M
- The global allergic conjunctivitis market was valued at $2.4 billion in 2020 and is projected to reach $3.6 billion by 2028, growing at a CAGR of 5.4%.
- Antihistamine & mast cell stabilizers accounted for the largest share of the market by drug class in 2020.
- North America accounted for 48% of the global market in 2020, with the US market valued at $1.16 billion that year.
- Recent advancements in allergic conjunctivitis therapeutics R&D are expected to drive market growth going forward.
The global blood preparation market is expected to reach $58.69 billion by 2022, driven by growing demand for blood transfusions and rising prevalence of blood-related disorders. Key factors fueling market growth include an increasing elderly population, commercialization of drugs in the product pipeline, and presence of advanced technologies for blood preparation and storage. The market is segmented by product, anti-thrombotic/anticoagulant type, and application. By product, plasma and blood components represent the largest segments. Geographically, North America accounts for the largest share currently but Asia Pacific is expected to experience the fastest growth over the forecast period.
The biocides market is expected to reach $14.81 billion by 2028, growing at a CAGR of 3.8% from 2021 to 2028. The market is segmented by product, application, and region. Key products include halogen compounds, metallic compounds, organosulfur compounds, and others. Main applications are water treatment, food and beverages, personal care, and others. Regionally, North America currently holds the largest market share, though Asia Pacific is expected to grow the fastest. The report also analyzes the impact of COVID-19 on the biocides market. Major players in the market include Troy Corporation, ChemTreat, Inc., Neogen Corporation, and others.
Medical Nonwoven Disposables Market Analysis, Size, Share, Growth To 2020 by...Grand View Research
Rapidly growing geriatric population base is another high impact rendering driver for the medical nonwoven disposables market as aging is considered as one of the greatest risk factor for the development of incontinence
For More Information Visit - http://www.grandviewresearch.com/industry-analysis/medical-nonwoven-disposables-market
Antibody market size to maintain the average annual growth rate of 12.69% from 5800 million $ in 2014 to 8300 million $ in 2017, Research analysts believe that in the next few years, Antibody market size will be further expanded, we expect that by 2022 , the market size of the Antibody will reach 14913 million $.
For More Details Visit: https://www.indexmarketsresearch.com/report/global-antibody-market-5/90056/
The edible Insect Market size is projected to reach USD 645.2 Million units by 2027 from an estimated USD 355.3 Million unit in 2019, growing at a CAGR of 22.4% globally.
"The Global Biostimulants Market is calculated to reach $4.61 billion by 2024. It is calculated to grow
with the CAGR of 11.12% during the forecast period 2019-2024. The organic food industry, which is
growing at a healthy rate, is the major driving force behind the growth of the biostimulant industry.
Increased awareness among the farmers about the benefits of biostimulants, is another factor
augmenting the growth of the market studied."
https://www.globalmarketstudies.com/product/biostimulants-market-report/
Gastrointestinal Pharmaceuticals: Technologies and MarketsReportLinker.com
Overall sales in the gastrointestinal disorder treatment market amounted to $34.2 billionin 2007, and decreased slightly to $31.1 billion in 2009. By 2014, they are projected to reach $32.2 billion, for a 5-year compound annual growth rate (CAGR) of 0.7%.The largest segment of the market, prescription gastrointestinal drugs, was valued at $27.4 billion in 2008; this is expected to decrease to $26,3 billion in 2009, and to reach $27 billion in 2014, for a 5-year CAGR of 0.5%.
Diabetic Retinopathy Market Analysis, Size, Segment To 2022 by Grand View Res...Grand View Research
Diabetic retinopathy is considered as a serious sight threatening complication that results due to long term diabetes.
For More Information Visit - http://www.grandviewresearch.com/industry-analysis/diabetic-retinopathy-market
INTRODUCTIONSTUDY GOALS AND OBJECTIVESBCC's goal in conducting this study was to understand the current status of the U.S. dermatological therapeutics industry and to assess it in the medium term from 2008 through 2013. We were particularly interested in understanding the future market potential for the current and emerging technologies and products within the dermatological therapeutics industry. This report assesses the available therapeutic procedures for skin, along with the drugs and technologies currently being used for various skin treatments. The role of public agencies, the regulatory environment, and non-governmental stakeholders has also been examined.REASONS FOR DOING THIS STUDYSkin disorders have a high active as well as passive morbidity in most human populations across the world. Yet, most dermatology manufacturers and dermatologists rely on cosmetic applications and procedures for survival.INTENDED AUDIENCEThis study is likely to be of interest to individuals and organizations involved in aspects of dermatological therapeutics industry, such as research, manufacturing and even large buyers in the industry. This report will also be of interest to manufacturers and marketers of dermatological therapeutics industry across the world.
Aminoglycosides Market Analysis By Drug, Mode of Administration, Application...Grand View Research
Aminoglycosides Market Analysis By Drug (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin), By Mode of Administration (Feed, Injectables (Parenteral), Intra-mammary, Topical, Oral), By Application (Veterinary, Skin, Respiratory, UTI & Pelvic Disease, Neonatal Sepsis) And Segment Forecasts To 2022
The document discusses the global anti-counterfeit packaging market from 2012-2020. It provides an overview of key drivers, restraints, and trends in the market. The market was valued at $57.4 billion in 2013 and is projected to reach $142.7 billion by 2020. The report analyzes the market by technology, application, and geography. It also profiles major companies in the market like Alien Technology Corp, AlpVision, and Zebra Technologies Corp.
Medical gases are gases that find indirect or direct applications in the healthcare industry and medical gas equipment are referred to the equipment utilized for the production of medical gases. Furthermore, medical gases are either directly administered to patients or are used in medical procedures mainly as coolants and sterilants.
The global allantoin market is expected to reach $641.7 million by 2022, growing at a CAGR of 5.2% from 2016 to 2022. Growing demand from the pharmaceutical and cosmetics industries is driving market growth. Cosmetics accounted for 33.7% of the market in 2014 due to allantoin's moisturizing and skin-softening properties. The Asia-Pacific region is expected to experience the fastest growth due to increasing demand from China and India. Key players are expanding production capacity to meet rising demand for allantoin.
The Canadian dermatological therapeutics market size stood at around USD 1.65 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The Canadian skincare industry is growing tremendously at xx% from 2015-2019 and is forecasted to grow by xx% (2020-2028), as more Canadians are investing in their skincare and the market is driven by an aging population looking for solutions to maintaining healthy skin and younger. Technological advancements and the increasing prevalence of skincare are anticipated to fuel the growth.
Market Drivers
Canada’s market is majorly driven by the rising burden of dermatology diseases. The skincare market is driven by the consumer attitude that is, to improve their quality of life in terms of looks and this attitude is visible across all the age groups. The Growing demand for anti-aging products and innovative and eco-friendly packaging designs are attributing to the market growth in the country. Canada’s skin allergy market is forecasted to grow by 3.9% over the 2020-2027 period. The extensive presence of online retail channels is also influencing sales of cosmetics in the country. The collective incidence of dermatological diseases and increasing levels of awareness-related disease progression, Etiology, and available therapies are leading to the high growth of dermatological therapeutics.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Global Schizophrenia Drug Market, By Type (Paranoid Schizophrenia, Hebephrenic Schizophrenia, Catatonic Schizophrenia and Undifferentiated Schizophrenia), By Treatment (Oral and Injectable), By Therapeutic Class (Second Generation Antipsychotics, (Risperdal (Risperidone), Invega (Paliperidone), Zyprexa (Olanzapine), Geodon (Ziprasidone), Seroquel (Quetiapine), Latuda (Lurasidone)) Third Generation Antipsychotics and Other Therapeutic Classes), By Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) – Market Trends, Analysis, and Forecast Till 2029.
Schizophrenia Drug Market is estimated to be US$ 9.8 Bn by 2030 with a CAGR o...ankitakalvankar
Schizophrenia Drug Market, By Type (Paranoid Schizophrenia, Hebephrenic Schizophrenia, Catatonic Schizophrenia and Undifferentiated Schizophrenia), By Treatment (Oral and Injectable), By Therapeutic Class (Second Generation Antipsychotics, (Risperdal (Risperidone), Invega (Paliperidone), Zyprexa (Olanzapine), Geodon (Ziprasidone), Seroquel (Quetiapine), Latuda (Lurasidone)) Third Generation Antipsychotics and Other Therapeutic Classes), By Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) – Market Trends, Analysis, and Forecast Till 2029.
Schizophrenia Drug Market is estimated to be US$ 9.8 Bn by 2030 with a CAGR o...ankitakalvankar
Schizophrenia Drug Market, By Type (Paranoid Schizophrenia, Hebephrenic Schizophrenia, Catatonic Schizophrenia and Undifferentiated Schizophrenia), By Treatment (Oral and Injectable), By Therapeutic Class (Second Generation Antipsychotics, (Risperdal (Risperidone), Invega (Paliperidone), Zyprexa (Olanzapine), Geodon (Ziprasidone), Seroquel (Quetiapine), Latuda (Lurasidone)) Third Generation Antipsychotics and Other Therapeutic Classes), By Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) – Market Trends, Analysis, and Forecast Till 2029.
Canada's dermatology market is projected to grow from $2.78 Bn in 2022 to $5.31 Bn in 2030 with a CAGR of 8.44% for the year 2022-2030. More Canadians investing in skincare solutions is driving the Canadian dermatology market. Major dermatological disorders in Canada are alopecia and psoriasis. To get a detailed report, contact us at - info@insights10.com
Nanomedicine is essentially based on the medical application of nanotechnology in diagnosing, treating and/or prevention of diseases and infections. Nanotechnology-based drugs and treatments are applied for treating cardiovascular, neurological, and oncology diseases.
Similar to Pruritus Therapeutics Market Forecast Report To 2020: Grand View Research, Inc. (20)
Essential Oil Market Analysis, Size, Share, Growth To 2022 by Grand View Rese...Grand View Research
Growing consumer awareness regarding heath benefits associated with natural and organic personal care products is expected to remain a key driving factor for global essential oil market over the forecast period.
For More Information Visit - http://www.grandviewresearch.com/industry-analysis/essential-oils-market
Wet Scrubber Market Size, Analysis To 2022: Grand View Research, Inc. Grand View Research
Global wet scrubber is expected to grow at a high pace over the forecast period on account of strict chemicals and emissions related industry standards by IMO, EPA and REACH. These scrubbers extract noxious pollutants & unwanted components from flue gas and helps in reducing pollution levels.
For More Information Visit - http://www.grandviewresearch.com/industry-analysis/wet-scrubber-market
Growing demand for high performance, light weight materials in automotive and aerospace industries is expected to remain a key driving factor for the global carbon fiber reinforced plastics (CFRP) market.
For More Information Visit - http://www.grandviewresearch.com/industry-analysis/carbon-fiber-market
Seafood Processing Equipment Market To 2022- Industry Trends, Forecast: Grand...Grand View Research
The global seafood processing equipment market is driven by increasing labor costs in the seafood industry and the long replacement life of processing equipment. This equipment processes seafood through methods like filtering, gutting, deboning, scaling, and curing. Mechanized processing has replaced traditional salting and drying techniques, improving safety and reducing labor. Technological advancements are also automating equipment and improving product quality. The market is expected to grow due to rising incomes increasing demand for processed seafood products with longer shelf lives. However, high equipment and material costs may slow market growth.
Smart Glass Market Growth, Trends, Segment To 2022: Grand View Research, Inc.Grand View Research
The global smart glass market is expected to reach $4.71 billion by 2022, growing at a CAGR of 22.9% between 2016 and 2022. Technological innovations have broadened the applications of smart glass across industries like transportation, architecture, electronics, and solar power generation. Increased demand from the construction and transportation sectors is expected to be a key driver of market growth over the next seven years. Liquid crystal is currently the largest and fastest growing technology segment due to its widespread use in automotive and architectural applications.
Plastic Compounding Market Analysis, Size, Share, Growth To 2022 by Grand Vie...Grand View Research
Increasing plastics demand across automotive, construction and electrical & electronics industries is expected to drive global plastic compounding market over the next seven years.
For More Information Visit - http://www.grandviewresearch.com/industry-analysis/plastic-compounding-market
The global smart glass market is expected to reach $4.71 billion by 2022, growing at a CAGR of 22.9% from 2016 to 2022. Contemporary technological innovations have broadened the use of smart glass in transportation, architecture, electronics, and solar power applications. Increased demand in construction and transportation industries is expected to drive market growth. Key players are focusing on partnerships, new product development, and expanding into emerging markets to gain market share.
IT Robotic Automation Market To 2022- Industry Trends, Forecast: Grand View R...Grand View Research
Robotic automation allows machines or computer software to mimic sequential tasks executed by humans. Automation helps in access management, request management, availability management, incident management, and problem management.
For More Information Visit - http://www.grandviewresearch.com/industry-analysis/global-it-robotic-automation-market
The document summarizes the global amino acids market. It finds that the market is expected to reach $35.40 billion by 2022, driven by increasing meat consumption and demand for dietary supplements. L-glutamic acid is currently the leading product segment. The market faces challenges from ensuring a steady supply of raw materials. The report provides an in-depth analysis of the market size and growth forecasts through 2022 for different amino acid products, sources, applications and regions. It gives market share and forecast data across segments in a detailed format.
The document discusses the global protein ingredients market. It states that the market is expected to reach USD 33.91 billion by 2020, driven by increasing demand for functional foods and protein fortification. The largest application segment is food and beverages, accounting for over 45% of the market in 2013. The market is segmented by product type into plant proteins like soy, wheat and pea, and animal/dairy proteins. The document provides historical and projected market sizes in terms of volume and revenue for major regions and application segments through 2020.
The global therapeutic respiratory devices market is expected to witness lucrative growth over the forecast period due to rising respiratory diseases and a shift towards home healthcare. Key drivers include new features in devices and increased awareness in Asia Pacific. The market is segmented by product type and region, with positive airway pressure devices and North America currently dominating. Major players are focusing on new technologies, marketing, and mergers to expand their market share.
The document discusses the global solar encapsulation market. Solar encapsulation involves protecting solar panels and equipment from physical and environmental threats to improve efficiency and reduce costs. The market is expected to grow due to concerns over depletion of fossil fuels and increasing electricity demand. However, higher solar panel installation costs and growth of alternative renewable energy sources may negatively impact the solar encapsulation market. Key players in the industry include STR Holdings, Hangzhou First PV Material, and Dow Corning.
The global laparotomy sponge market is expected to grow significantly over the next seven years due to technological advancements and an increasing prevalence of abdominal diseases like colon cancer. The market is segmented based on type (sterile vs. non-sterile) and medical procedures (pre-washed vs. non-washed). North America currently dominates the market but Asia Pacific is anticipated to experience rapid growth. Key players are focusing on new product development and marketing strategies to increase their market share in this growing industry.
The global polyurethane market is expected to reach $73.6 billion by 2020, growing at a CAGR of 5.9% from 2014 to 2020. Furniture and interiors applications currently dominate the market. Asia Pacific accounts for the largest market share due to increasing construction spending and demand from automotive and electronics industries in China and India. Low feedstock pricing in the region also benefits producers. The market is driven by usage of polyurethane in automotive, appliances and construction applications. Key players are focusing on emerging markets for further growth opportunities.
The document discusses the lactoferrin market. It states that the global lactoferrin market is expected to grow due to increasing use of lactoferrin in functional foods and as a food additive. The market is also expected to expand due to greater use of lactoferrin in sports nutrition, infant formula, pharmaceuticals, and personal care products. Key players in the lactoferrin market include Fonterra, Ventrua Bioscience, Pharming, and Synlait Milk Limited.
The document discusses the military radar market from 2015 to 2022. It states that the market is expected to grow substantially due to increasing demand for improved security services and progress in technology overcoming outdated equipment. The major factors driving the market are rising numbers of lightweight radars used on UAVs. Renewal/modernization programs and increased procurement for safety are also influencing growth, while budget limitations and wind turbines posing risks to weather radars may hinder the market. The market is anticipated to be led by growing airborne radar systems to meet security/economic concerns.
Plastic Compounding Market Analysis, Growth, Trends To 2022: Grand View Resea...Grand View Research
Increasing plastics demand across automotive, construction and electrical & electronics industries is expected to drive global plastic compounding market over the next seven years.
For More Information Visit - http://www.grandviewresearch.com/industry-analysis/plastic-compounding-market
The global lubricants market is expected to reach $70.32 billion by 2020, driven by growth in the automotive and industrial sectors. Industrial lubricants currently account for the largest share of the market at 38.6%. Within industrial lubricants, general industrial oils are the most consumed. Consumer automotive lubricants are forecasted to be the fastest growing segment. The market is regionally concentrated, with Asia Pacific having the largest share due to rapid industrialization in China and India.
Capsule Endoscopy Market Analysis, Growth, Trends To 2022: Grand View Researc...Grand View Research
Increasing prevalence of colorectal cancer, GI diseases and growing demand for precise and accurate diagnostic tools are expected to drive the capsule endoscopy market over the forecast period.
For More Information Visit - http://www.grandviewresearch.com/industry-analysis/capsule-endoscopes-market
The global handheld imagers market is expected to reach $3.45 billion by 2022, driven by technological advancements and increasing demand across various applications such as security, construction, and medical. Key product segments include IR scanners, stud finders, millimeter wave scanners, and microbolometers. The security industry is a major end user due to growing security concerns. North America currently dominates the market but Asia Pacific is expected to experience strong growth. Key players are focusing on innovations and expanding their presence to gain market share.
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDr Rachana Gujar
Introduction: Substance use education is crucial due to its prevalence and societal impact.
Alcohol Use: Immediate and long-term risks include impaired judgment, health issues, and social consequences.
Tobacco Use: Immediate effects include increased heart rate, while long-term risks encompass cancer and heart disease.
Drug Use: Risks vary depending on the drug type, including health and psychological implications.
Prevention Strategies: Education, healthy coping mechanisms, community support, and policies are vital in preventing substance use.
Harm Reduction Strategies: Safe use practices, medication-assisted treatment, and naloxone availability aim to reduce harm.
Seeking Help for Addiction: Recognizing signs, available treatments, support systems, and resources are essential for recovery.
Personal Stories: Real stories of recovery emphasize hope and resilience.
Interactive Q&A: Engage the audience and encourage discussion.
Conclusion: Recap key points and emphasize the importance of awareness, prevention, and seeking help.
Resources: Provide contact information and links for further support.
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...nirahealhty
The South Beach Coffee Java Diet is a variation of the popular South Beach Diet, which was developed by cardiologist Dr. Arthur Agatston. The original South Beach Diet focuses on consuming lean proteins, healthy fats, and low-glycemic index carbohydrates. The South Beach Coffee Java Diet adds the element of coffee, specifically caffeine, to enhance weight loss and improve energy levels.
R3 Stem Cell Therapy: A New Hope for Women with Ovarian FailureR3 Stem Cell
Discover the groundbreaking advancements in stem cell therapy by R3 Stem Cell, offering new hope for women with ovarian failure. This innovative treatment aims to restore ovarian function, improve fertility, and enhance overall well-being, revolutionizing reproductive health for women worldwide.
2024 HIPAA Compliance Training Guide to the Compliance OfficersConference Panel
Join us for a comprehensive 90-minute lesson designed specifically for Compliance Officers and Practice/Business Managers. This 2024 HIPAA Training session will guide you through the critical steps needed to ensure your practice is fully prepared for upcoming audits. Key updates and significant changes under the Omnibus Rule will be covered, along with the latest applicable updates for 2024.
Key Areas Covered:
Texting and Email Communication: Understand the compliance requirements for electronic communication.
Encryption Standards: Learn what is necessary and what is overhyped.
Medical Messaging and Voice Data: Ensure secure handling of sensitive information.
IT Risk Factors: Identify and mitigate risks related to your IT infrastructure.
Why Attend:
Expert Instructor: Brian Tuttle, with over 20 years in Health IT and Compliance Consulting, brings invaluable experience and knowledge, including insights from over 1000 risk assessments and direct dealings with Office of Civil Rights HIPAA auditors.
Actionable Insights: Receive practical advice on preparing for audits and avoiding common mistakes.
Clarity on Compliance: Clear up misconceptions and understand the reality of HIPAA regulations.
Ensure your compliance strategy is up-to-date and effective. Enroll now and be prepared for the 2024 HIPAA audits.
Enroll Now to secure your spot in this crucial training session and ensure your HIPAA compliance is robust and audit-ready.
https://conferencepanel.com/conference/hipaa-training-for-the-compliance-officer-2024-updates
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Can Allopathy and Homeopathy Be Used Together in India.pdfDharma Homoeopathy
This article explores the potential for combining allopathy and homeopathy in India, examining the benefits, challenges, and the emerging field of integrative medicine.
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
Joker Wigs has been a one-stop-shop for hair products for over 26 years. We provide high-quality hair wigs, hair extensions, hair toppers, hair patch, and more for both men and women.
At Apollo Hospital, Lucknow, U.P., we provide specialized care for children experiencing dehydration and other symptoms. We also offer NICU & PICU Ambulance Facility Services. Consult our expert today for the best pediatric emergency care.
For More Details:
Map: https://cutt.ly/BwCeflYo
Name: Apollo Hospital
Address: Singar Nagar, LDA Colony, Lucknow, Uttar Pradesh 226012
Phone: 08429021957
Opening Hours: 24X7
Pediatric Emergency Care for Children | Apollo Hospital
Pruritus Therapeutics Market Forecast Report To 2020: Grand View Research, Inc.
1. Pruritus Therapeutics Market By Product (Corticosteroids,
Antihistamines, Local Anesthetics, Counterirritants,
Immunosuppressant, Calcineurin Inhibitors, Pipeline,
Unmet Needs), By Disease Type Is Expected To Reach USD
16.38 Billion By 2025
Global pruritus therapeutics market is expected to reach USD 16.38 Billion by 2025, according
to a new study by Grand View Research, Inc. Growing worldwide prevalence of atopic
dermatitis, allergic contact dermatitis and urticaria is expected to drive market growth during the
forecast period. Introduction of new products based on scientific mechanistic understanding such
as the identification of new T-cell subsets, particularly Th17, and Th22 and the patent expiration
of PROTOPIC (tacrolimus) is expected to open up new avenues for manufacturers to capitalize
on over the forecast period. Corticosteroids were the leading product segment in 2013 owing to
high efficacy exhibited by this class of drugs in treating pruritic conditions by reducing
inflammation and itching. Topical applications of corticosteroids have been found to be
extremely effective in the treatment and maintenance therapies pertaining to pruritus.
View summary of this report @ http://www.grandviewresearch.com/industry-
analysis/pruritus-therapeutics-market
2. Global pruritus therapeutics market, by product, 2012 – 2025 (USD Million)
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Pruritus Therapeutics Industry Outlook
2.1 Market Segmentation
2.2 Market size and growth prospects
2.3 Pruritus therapeutics – Market dynamics
2.3.1 Market driver analysis
2.3.1.1 Growing prevalence of atopic dermatitis, allergic contact dermatitis and
urticaria
2.3.1.1.1 Global prevalence atopic dermatitis
2.3.1.1.2 U.S. prevalence of atopic dermatitis, allergic contact dermatitis,
urticaria
2.3.1.2 Presence of a strong pipeline product portfolio
2.3.2 Market restraint analysis
2.3.2.1 Lack of therapeutics based on scientific mechanistic understanding
2.4 Key Opportunities Prioritized
2.6 Pruritus therapeutics – PESTEL analysis
2.7 Unmet needs analysis
5. 4.4 Asia Pacific
4.4.1 Asia Pacific pruritus therapeutics market, 2012 - 2025 (USD Million)
4.4.2 Japan
4.4.3 Rest of Asia Pacific
4.5 RoW
4.5.1 RoW pruritus therapeutics market, 2012 - 2025 (USD Million)
Chapter 5 Competitive Landscape
5.1 Sanofi
5.1.1 Company Overview
5.1.2 Financial Performance
5.1.3 Product Benchmarking
5.1.4 Strategic Initiatives
5.2 Pfizer
5.2.1 Company Overview
5.2.2 Financial Performance
5.2.3 Product Benchmarking
5.3 Tai Guk Pharmaceutical Company
5.3.1 Company Overview
5.3.2 Financial Performance
5.3.3 Product Benchmarking
5.4 Actavis
5.4.1 Company Overview
5.4.2 Financial Performance
5.4.3 Product Benchmarking
5.5 Trevi Therapeutics
5.5.1 Company Overview
5.5.2 Financial Performance
5.5.3 Product Benchmarking
5.5.4 Strategic Initiatives
5.6 Cara Therapeutics
5.6.1 Company Overview
5.6.2 Financial Performance
5.6.3 Product Benchmarking
5.6.4 Strategic Initiatives
5.7 Ocera Therapeutics Inc.
5.7.1 Company Overview
5.7.2 Financial Performance
5.7.3 Product Benchmarking
5.8 NeRRe Therapeutics
5.8.1 Company Overview
5.8.2 Financial Performance
5.8.3 Product Benchmarking
5.8.4 Strategic initiatives
6. Chapter 6 Methodology and Scope
6.1 Research Methodology
6.2 Research Scope & Assumptions
6.3 List of Data Sources
Browse full report @ http://www.grandviewresearch.com/industry-analysis/pruritus-
therapeutics-market
List of Tables
TABLE 1 Pruritus Therapeutics Market - Industry Summary & Critical Success Factors (CSFs)
TABLE 2 Pruritus therapeutics market, by product, 2012 – 2020 (USD Million)
TABLE 3 Pruritus therapeutics market, by product, 2021 – 2025 (USD Million)
TABLE 4 Pruritus therapeutics market, by region, 2012 – 2020 (USD Million)
TABLE 5 Pruritus therapeutics market, by region, 2021 – 2025 (USD Million)
TABLE 6 Pruritus therapeutics – Key market driver analysis
TABLE 7 Pruritus therapeutics – Key market restraint analysis
TABLE 8 Pruritus therapeutics market – Pipeline overview
TABLE 9 Global prevalence rate of pruritus, 2012 - 2018 (Million)
TABLE 10 Global prevalence rate of pruritus, 2019 - 2025 (Million)
TABLE 11 Global prevalence of chronic pruritus, 2012 (%)
TABLE 12 Global incidence rate of pruritus, 2012- 2018 (Million)
TABLE 13 Global incidence rate of pruritus, 2019 - 2025 (Million)
TABLE 14 Global prevalence of pruritus in atopic dermatitis, 2012 - 2018 (Million)
TABLE 15 Global prevalence of pruritus in atopic dermatitis, 2019 - 2025 (Million)
TABLE 16 Lifetime prevalence of allergic contact dermatitis, (%)
TABLE 17 North America pruritus therapeutics market, by product, 2012 - 2020 (USD Million)
TABLE 18 North America pruritus therapeutics market, by product, 2021 - 2025 (USD Million)
TABLE 19 North America corticosteroids pruritus therapeutics market, by product, 2012 - 2020
(USD Million)
TABLE 20 North America corticosteroids pruritus therapeutics market, by product, 2021 - 2025
(USD Million)
TABLE 21 North America corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 22 North America corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
7. TABLE 23 North America topical corticosteroids pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 24 North America topical corticosteroids pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 25 North America systemic corticosteroids pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 26 North America systemic corticosteroids pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 27 North America antihistamines pruritus therapeutics market, by product, 2012 - 2020
(USD Million)
TABLE 28 North America antihistamines pruritus therapeutics market, by product, 2021 - 2025
(USD Million)
TABLE 29 North America antihistamines pruritus therapeutics market, by disease type, 2012 -
2020 (USD Million)
TABLE 30 North America antihistamines pruritus therapeutics market, by disease type, 2021 -
2025 (USD Million)
TABLE 31 North America topical antihistamines pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 32 North America topical antihistamines pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 33 North America systemic antihistamines pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 34 North America systemic antihistamines pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 35 North America local anesthetics pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 36 North America local anesthetics pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 37 North America counterirritants pruritus therapeutics market, by disease type 2012 -
2025 (USD Million)
TABLE 38 North America counterirritants pruritus therapeutics market, by disease type 2012 -
2025 (USD Million)
TABLE 39 North America immunosuppressant pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 40 North America immunosuppressant pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 41 North America calcineurin inhibitors pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
8. TABLE 42 North America calcineurin inhibitors pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 43 North America other pruritus therapeutics market, by disease type 2012 - 2020 (USD
Million)
TABLE 44 North America other pruritus therapeutics market, by disease type 2021 - 2025 (USD
Million)
TABLE 45 U.S. pruritus therapeutics market, by product, 2012 - 2020 (USD Million)
TABLE 46 U.S. pruritus therapeutics market, by product, 2021 - 2025 (USD Million)
TABLE 47 U.S. corticosteroids pruritus therapeutics market, by product, 2012 - 2020 (USD
Million)
TABLE 48 U.S. corticosteroids pruritus therapeutics market, by product, 2021 - 2025 (USD
Million)
TABLE 49 U.S. corticosteroids pruritus therapeutics market, by disease type 2012 - 2020 (USD
Million)
TABLE 50 U.S. corticosteroids pruritus therapeutics market, by disease type 2021 - 2025 (USD
Million)
TABLE 51 U.S. topical corticosteroids pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 52 U.S. topical corticosteroids pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 53 U.S. systemic corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 54 U.S. systemic corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 55 U.S. antihistamines pruritus therapeutics market, by product, 2012 - 2020 (USD
Million)
TABLE 56 U.S. antihistamines pruritus therapeutics market, by product, 2021 - 2025 (USD
Million)
TABLE 57 U.S. antihistamines pruritus therapeutics market, by disease type, 2012 - 2020 (USD
Million)
TABLE 58 U.S. antihistamines pruritus therapeutics market, by disease type, 2021 - 2025 (USD
Million)
TABLE 59 U.S. topical antihistamines pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 60 U.S. topical antihistamines pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 61 U.S. systemic antihistamines pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
9. TABLE 62 U.S. systemic antihistamines pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 63 U.S. local anesthetics pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 64 U.S. local anesthetics pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 65 U.S. counterirritants pruritus therapeutics market, by disease type 2012 - 2025 (USD
Million)
TABLE 66 U.S. counterirritants pruritus therapeutics market, by disease type 2012 - 2025 (USD
Million)
TABLE 67 U.S. immunosuppressant pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 68 U.S. immunosuppressant pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 69 U.S. calcineurin inhibitors pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 70 U.S. calcineurin inhibitors pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 71 U.S. other pruritus therapeutics market, by disease type 2012 - 2020 (USD Million)
TABLE 72 U.S. other pruritus therapeutics market, by disease type 2021 - 2025 (USD Million)
TABLE 73 Rest of North America pruritus therapeutics market, by product, 2012 - 2020 (USD
Million)
TABLE 74 Rest of North America pruritus therapeutics market, by product, 2021 - 2025 (USD
Million)
TABLE 75 Rest of North America corticosteroids pruritus therapeutics market, by product, 2012
- 2020 (USD Million)
TABLE 76 Rest of North America corticosteroids pruritus therapeutics market, by product, 2021
- 2025 (USD Million)
TABLE 77 Rest of North America corticosteroids pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 78 Rest of North America corticosteroids pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 79 Rest of North America topical corticosteroids pruritus therapeutics market, by
disease type 2012 - 2020 (USD Million)
TABLE 80 Rest of North America topical corticosteroids pruritus therapeutics market, by
disease type 2021 - 2025 (USD Million)
TABLE 81 Rest of North America systemic corticosteroids pruritus therapeutics market, by
disease type 2012 - 2020 (USD Million)
10. TABLE 82 Rest of North America systemic corticosteroids pruritus therapeutics market, by
disease type 2021 - 2025 (USD Million)
TABLE 83 Rest of North America antihistamines pruritus therapeutics market, by product, 2012
- 2020 (USD Million)
TABLE 84 Rest of North America antihistamines pruritus therapeutics market, by product, 2021
- 2025 (USD Million)
TABLE 85 Rest of North America antihistamines pruritus therapeutics market, by disease type,
2012 - 2020 (USD Million)
TABLE 86 Rest of North America antihistamines pruritus therapeutics market, by disease type,
2021 - 2025 (USD Million)
TABLE 87 Rest of North America topical antihistamines pruritus therapeutics market, by disease
type 2012 - 2020 (USD Million)
TABLE 88 Rest of North America topical antihistamines pruritus therapeutics market, by disease
type 2021 - 2025 (USD Million)
TABLE 89 Rest of North America systemic antihistamines pruritus therapeutics market, by
disease type 2012 - 2020 (USD Million)
TABLE 90 Rest of North America Systemic antihistamines pruritus therapeutics market, by
disease type 2021 - 2025 (USD Million)
TABLE 91 Rest of North America local anesthetics pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 92 Rest of North America local anesthetics pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 93 Rest of North America counterirritants pruritus therapeutics market, by disease type
2012 - 2025 (USD Million)
TABLE 94 Rest of North America counterirritants pruritus therapeutics market, by disease type
2012 - 2025 (USD Million)
TABLE 95 Rest of North America immunosuppressant pruritus therapeutics market, by disease
type 2012 - 2020 (USD Million)
TABLE 96 Rest of North America immunosuppressant pruritus therapeutics market, by disease
type 2021 - 2025 (USD Million)
TABLE 97 Rest of North America calcineurin inhibitors pruritus therapeutics market, by disease
type 2012 - 2020 (USD Million)
TABLE 98 Rest of North America calcineurin inhibitors pruritus therapeutics market, by disease
type 2021 - 2025 (USD Million)
TABLE 99 Rest of North America other pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 100 Rest of North America other pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
11. TABLE 101 Europe pruritus therapeutics market, by product, 2012 - 2020 (USD Million)
TABLE 102 Europe pruritus therapeutics market, by product, 2021 - 2025 (USD Million)
TABLE 103 Europe corticosteroids pruritus therapeutics market, by product, 2012 - 2020 (USD
Million)
TABLE 104 Europe corticosteroids pruritus therapeutics market, by product, 2021 - 2025 (USD
Million)
TABLE 105 Europe corticosteroids pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 106 Europe corticosteroids pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 107 Europe topical corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 108 Europe topical corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 109 Europe systemic corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 110 Europe systemic corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 111 Europe Antihistamines Pruritus Therapeutics Market, by product, 2012 - 2020
(USD Million)
TABLE 112 Europe Antihistamines Pruritus Therapeutics Market, by product, 2021 - 2025
(USD Million)
TABLE 113 Europe antihistamines pruritus therapeutics market, by disease type, 2012 - 2020
(USD Million)
TABLE 114 Europe antihistamines pruritus therapeutics market, by disease type, 2021 - 2025
(USD Million)
TABLE 115 Europe topical antihistamines pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 116 Europe topical antihistamines pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 117 Europe systemic antihistamines pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 118 Europe systemic antihistamines pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 119 Europe local anesthetics pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 120 Europe local anesthetics pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
12. TABLE 121 Europe counterirritants pruritus therapeutics market, by disease type 2012 - 2025
(USD Million)
TABLE 122 Europe counterirritants pruritus therapeutics market, by disease type 2012 - 2025
(USD Million)
TABLE 123 Europe immunosuppressant pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 124 Europe immunosuppressant pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 125 Europe calcineurin inhibitors pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 126 Europe calcineurin inhibitors pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 127 Europe other pruritus therapeutics market, by disease type 2012 - 2020 (USD
Million)
TABLE 128 Europe other pruritus therapeutics market, by disease type 2021 - 2025 (USD
Million)
TABLE 129 Germany pruritus therapeutics market, by product, 2012 - 2020 (USD Million)
TABLE 130 Germany pruritus therapeutics market, by product, 2021 - 2025 (USD Million)
TABLE 131 Germany corticosteroids pruritus therapeutics market, by product, 2012 - 2020
(USD Million)
TABLE 132 Germany corticosteroids pruritus therapeutics market, by product, 2021 - 2025
(USD Million)
TABLE 133 Germany corticosteroids pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 134 Germany corticosteroids pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 135 Germany topical corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 136 Germany topical corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 137 Germany systemic corticosteroids pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 138 Germany systemic corticosteroids pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 139 Germany antihistamines pruritus therapeutics market, by product, 2012 - 2020
(USD Million)
TABLE 140 Germany antihistamines pruritus therapeutics market, by product, 2021 - 2025
(USD Million)
13. TABLE 141 Germany antihistamines pruritus therapeutics market, by disease type, 2012 - 2020
(USD Million)
TABLE 142 Germany antihistamines pruritus therapeutics market, by disease type, 2021 - 2025
(USD Million)
TABLE 143 Germany topical antihistamines pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 144 Germany topical antihistamines pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 145 Germany systemic antihistamines pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 146 Germany systemic antihistamines pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 147 Germany local anesthetics pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 148 Germany local anesthetics pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 149 Germany counterirritants pruritus therapeutics market, by disease type 2012 - 2025
(USD Million)
TABLE 150 Germany counterirritants pruritus therapeutics market, by disease type 2012 - 2025
(USD Million)
TABLE 151 Germany immunosuppressant pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 152 Germany immunosuppressant pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 153 Germany calcineurin inhibitors pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 154 Germany calcineurin inhibitors pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 155 Germany other pruritus therapeutics market, by disease type 2012 - 2020 (USD
Million)
TABLE 156 Germany other pruritus therapeutics market, by disease type 2021 - 2025 (USD
Million)
TABLE 157 UK pruritus therapeutics market, by product, 2012 - 2020 (USD Million)
TABLE 158 UK pruritus therapeutics market, by product, 2021 - 2025 (USD Million)
TABLE 159 UK corticosteroids pruritus therapeutics market, by product, 2012 - 2020 (USD
Million)
TABLE 160 UK corticosteroids pruritus therapeutics market, by product, 2021 - 2025 (USD
Million)
14. TABLE 161 UK corticosteroids pruritus therapeutics market, by disease type 2012 - 2020 (USD
Million)
TABLE 162 UK corticosteroids pruritus therapeutics market, by disease type 2021 - 2025 (USD
Million)
TABLE 163 UK topical corticosteroids pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 164 UK topical corticosteroids pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 165 UK systemic corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 166 UK systemic corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 167 UK Antihistamines Pruritus Therapeutics Market, by product, 2012 - 2020 (USD
Million)
TABLE 168 UK Antihistamines Pruritus Therapeutics Market, by product, 2021 - 2025 (USD
Million)
TABLE 169 UK antihistamines pruritus therapeutics market, by disease type, 2012 - 2020 (USD
Million)
TABLE 170 UK antihistamines pruritus therapeutics market, by disease type, 2021 - 2025 (USD
Million)
TABLE 171 UK topical antihistamines pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 172 UK topical antihistamines pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 173 UK systemic antihistamines pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 174 UK systemic antihistamines pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 175 UK local anesthetics pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 176 UK local anesthetics pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 177 UK counterirritants pruritus therapeutics market, by disease type 2012 - 2025 (USD
Million)
TABLE 178 UK counterirritants pruritus therapeutics market, by disease type 2012 - 2025 (USD
Million)
TABLE 179 UK immunosuppressant pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
15. TABLE 180 UK immunosuppressant pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 181 UK calcineurin inhibitors pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 182 UK calcineurin inhibitors pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 183 UK other pruritus therapeutics market, by disease type 2012 - 2020 (USD Million)
TABLE 184 UK other pruritus therapeutics market, by disease type 2021 - 2025 (USD Million)
TABLE 185 France pruritus therapeutics market, by product, 2012 - 2020 (USD Million)
TABLE 186 France pruritus therapeutics market, by product, 2021 - 2025 (USD Million)
TABLE 187 France corticosteroids pruritus therapeutics market, by product, 2012 - 2020 (USD
Million)
TABLE 188 France corticosteroids pruritus therapeutics market, by product, 2021 - 2025 (USD
Million)
TABLE 189 France corticosteroids pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 190 France corticosteroids pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 191 France topical corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 192 France topical corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 193 France systemic corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 194 France systemic corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 195 France antihistamines pruritus therapeutics market, by product, 2012 - 2020 (USD
Million)
TABLE 196 France antihistamines pruritus therapeutics market, by product, 2021 - 2025 (USD
Million)
TABLE 197 France antihistamines pruritus therapeutics market, by disease, 2012 - 2020 (USD
Million)
TABLE 198 France antihistamines pruritus therapeutics market, by disease, 2021 - 2025 (USD
Million)
TABLE 199 France topical antihistamines pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 200 France topical antihistamines pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
16. TABLE 201 France systemic antihistamines pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 202 France systemic antihistamines pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 203 France Local anesthetics pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 204 France local anesthetics pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 205 France counterirritants pruritus therapeutics market, by disease type 2012 - 2025
(USD Million)
TABLE 206 France counterirritants pruritus therapeutics market, by disease type 2012 - 2025
(USD Million)
TABLE 207 France immunosuppressant pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 208 France immunosuppressant pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 209 France calcineurin inhibitors pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 210 France calcineurin inhibitors pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 211 France other pruritus therapeutics market, by disease type 2012 - 2020 (USD
Million)
TABLE 212 France other pruritus therapeutics market, by disease type 2021 - 2025 (USD
Million)
TABLE 213 Italy pruritus therapeutics market, by product, 2012 - 2020 (USD Million)
TABLE 214 Italy pruritus therapeutics market, by product, 2021 - 2025 (USD Million)
TABLE 215 Italy corticosteroids pruritus therapeutics market, by product, 2012 - 2020 (USD
Million)
TABLE 216 Italy corticosteroids pruritus therapeutics market, by product, 2021 - 2025 (USD
Million)
TABLE 217 Italy corticosteroids pruritus therapeutics market, by disease type 2012 - 2020 (USD
Million)
TABLE 218 Italy corticosteroids pruritus therapeutics market, by disease type 2021 - 2025 (USD
Million)
TABLE 219 Italy topical corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 220 Italy topical corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
17. TABLE 221 Italy systemic corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 222 Italy systemic corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 223 Italy Antihistamines Pruritus Therapeutics Market, by product, 2012 - 2020 (USD
Million)
TABLE 224 Italy Antihistamines Pruritus Therapeutics Market, by product, 2021 - 2025 (USD
Million)
TABLE 225 Italy antihistamines pruritus therapeutics market, by disease, 2012 - 2020 (USD
Million)
TABLE 226 Italy antihistamines pruritus therapeutics market, by disease, 2021 - 2025 (USD
Million)
TABLE 227 Italy topical antihistamines pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 228 Italy topical antihistamines pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 229 Italy systemic antihistamines pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 230 Italy systemic antihistamines pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 231 Italy local anesthetics pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 232 Italy local anesthetics pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 233 Italy counterirritants pruritus therapeutics market, by disease type 2012 - 2025
(USD Million)
TABLE 234 Italy counterirritants pruritus therapeutics market, by disease type 2012 - 2025
(USD Million)
TABLE 235 Italy immunosuppressant pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 236 Italy immunosuppressant pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 237 Italy calcineurin inhibitors pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 238 Italy calcineurin inhibitors pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 239 Italy other pruritus therapeutics market, by disease type, 2012 - 2020 (USD Million)
TABLE 240 Italy other pruritus therapeutics market, by disease type, 2021 - 2025 (USD Million)
18. TABLE 241 Spain pruritus therapeutics market, by product, 2012 - 2020 (USD Million)
TABLE 242 Spain pruritus therapeutics market, by product, 2021 - 2025 (USD Million)
TABLE 243 Spain corticosteroids pruritus therapeutics market, by product, 2012 - 2020 (USD
Million)
TABLE 244 Spain corticosteroids pruritus therapeutics market, by product, 2021 - 2025 (USD
Million)
TABLE 245 Spain corticosteroids pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 246 Spain corticosteroids pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 247 Spain topical corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 248 Spain topical corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 249 Spain systemic corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 250 Spain systemic corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 251 Spain Antihistamines Pruritus Therapeutics Market, by product, 2012 - 2020 (USD
Million)
TABLE 252 Spain Antihistamines Pruritus Therapeutics Market, by product, 2021 - 2025 (USD
Million)
TABLE 253 Spain antihistamines pruritus therapeutics market, by disease type, 2012 - 2020
(USD Million)
TABLE 254 Spain antihistamines pruritus therapeutics market, by disease type, 2021 - 2025
(USD Million)
TABLE 255 Spain topical antihistamines pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 256 Spain topical antihistamines pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 257 Spain systemic antihistamines pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 258 Spain systemic antihistamines pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 259 Spain local anesthetics pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 260 Spain local anesthetics pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
19. TABLE 261 Spain counterirritants pruritus therapeutics market, by disease type 2012 - 2025
(USD Million)
TABLE 262 Spain counterirritants pruritus therapeutics market, by disease type 2012 - 2025
(USD Million)
TABLE 263 Spain immunosuppressant pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 264 Spain immunosuppressant pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 265 Spain calcineurin inhibitors pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 266 Spain calcineurin inhibitors pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 267 Spain other pruritus therapeutics market, by disease type 2012 - 2020 (USD
Million)
TABLE 268 Spain other pruritus therapeutics market, by disease type 2021 - 2025 (USD
Million)
TABLE 269 Rest of Europe pruritus therapeutics market, by product, 2012 - 2020 (USD Million)
TABLE 270 Rest of Europe pruritus therapeutics market, by product, 2021 - 2025 (USD Million)
TABLE 271 Rest of Europe corticosteroids pruritus therapeutics market, by product, 2012 - 2020
(USD Million)
TABLE 272 Rest of Europe corticosteroids pruritus therapeutics market, by product, 2021 - 2025
(USD Million)
TABLE 273 Rest of Europe corticosteroids pruritus therapeutics market, by disease type, 2012 -
2020 (USD Million)
TABLE 274 Rest of Europe corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 275 Rest of Europe topical corticosteroids pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 276 Rest of Europe topical corticosteroids pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 277 Rest of Europe systemic corticosteroids pruritus therapeutics market, by disease
type 2012 - 2020 (USD Million)
TABLE 278 Rest of Europe systemic corticosteroids pruritus therapeutics market, by disease
type 2021 - 2025 (USD Million)
TABLE 279 Rest of Europe Antihistamines Pruritus Therapeutics Market, by product, 2012 -
2020 (USD Million)
TABLE 280 Rest of Europe Antihistamines Pruritus Therapeutics Market, by product, 2021 -
2025 (USD Million)
20. TABLE 281 Rest of Europe antihistamines pruritus therapeutics market, by disease type, 2012 -
2020 (USD Million)
TABLE 282 Rest of Europe antihistamines pruritus therapeutics market, by disease type, 2021 -
2025 (USD Million)
TABLE 283 Rest of Europe topical antihistamines pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 284 Rest of Europe topical antihistamines pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 285 Rest of Europe systemic antihistamines pruritus therapeutics market, by disease
type 2012 - 2020 (USD Million)
TABLE 286 Rest of Europe systemic antihistamines pruritus therapeutics market, by disease
type 2021 - 2025 (USD Million)
TABLE 287 Rest of Europe local anesthetics pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 288 Rest of Europe local anesthetics pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 289 Rest Of Europe counterirritants pruritus therapeutics market, by disease type 2012 -
2025 (USD Million)
TABLE 290 Rest of Europe counterirritants pruritus therapeutics market, by disease type 2012 -
2025 (USD Million)
TABLE 291 Rest of Europe immunosuppressant pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 292 Rest of Europe immunosuppressant pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 293 Rest Of Europe calcineurin inhibitors pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 294 Rest of Europe calcineurin inhibitors pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 295 Rest of Europe other pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 296 Rest of Europe Other pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 297 Asia Pacific pruritus therapeutics market, by product, 2012 - 2020 (USD Million)
TABLE 298 Asia Pacific pruritus therapeutics market, by product, 2021 - 2025 (USD Million)
TABLE 299 Asia Pacific corticosteroids pruritus therapeutics market, by product, 2012 - 2020
(USD Million)
TABLE 300 Asia Pacific corticosteroids pruritus therapeutics market, by product, 2021 - 2025
(USD Million)
21. TABLE 301 Asia Pacific corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 302 Asia Pacific corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 303 Asia Pacific topical corticosteroids pruritus therapeutics market, by disease type,
2012 - 2020 (USD Million)
TABLE 304 Asia Pacific topical corticosteroids pruritus therapeutics market, by disease type,
2021 - 2025 (USD Million)
TABLE 305 Asia Pacific systemic corticosteroids pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 306 Asia Pacific systemic corticosteroids pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 307 Asia Pacific Antihistamines Pruritus Therapeutics Market, by product, 2012 - 2020
(USD Million)
TABLE 308 Asia Pacific Antihistamines Pruritus Therapeutics Market, by product, 2021 - 2025
(USD Million)
TABLE 309 Asia Pacific antihistamines pruritus therapeutics market, by disease type, 2012 -
2020 (USD Million)
TABLE 310 Asia Pacific antihistamines pruritus therapeutics market, by disease type, 2021 -
2025 (USD Million)
TABLE 311 Asia Pacific topical antihistamines pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 312 Asia Pacific topical antihistamines pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 313 Asia Pacific systemic antihistamines pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 314 Asia Pacific systemic antihistamines pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 315 Asia Pacific local anesthetics pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 316 Asia Pacific local anesthetics pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 317 Asia Pacific counterirritants pruritus therapeutics market, by disease type 2012 -
2025 (USD Million)
TABLE 318 Asia Pacific counterirritants pruritus therapeutics market, by disease type 2012 -
2025 (USD Million)
TABLE 319 Asia Pacific immunosuppressant pruritus therapeutics market, by disease type 2012
- 2020 (USD Million)
22. TABLE 320 Asia Pacific immunosuppressant pruritus therapeutics market, by disease type 2021
- 2025 (USD Million)
TABLE 321 Asia Pacific calcineurin inhibitors pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 322 Asia Pacific calcineurin inhibitors pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 323 Asia Pacific other pruritus therapeutics market, by disease type 2012 - 2020 (USD
Million)
TABLE 324 Asia Pacific other pruritus therapeutics market, by disease type 2021 - 2025 (USD
Million)
TABLE 325 Japan pruritus therapeutics market, by product, 2012 - 2020 (USD Million)
TABLE 326 Japan pruritus therapeutics market, by product, 2021 - 2025 (USD Million)
TABLE 327 Japan corticosteroids pruritus therapeutics market, by product, 2012 - 2020 (USD
Million)
TABLE 328 Japan corticosteroids pruritus therapeutics market, by product, 2021 - 2025 (USD
Million)
TABLE 329 Japan corticosteroids pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 330 Japan corticosteroids pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 331 Japan topical corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 332 Japan topical corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 333 Japan systemic corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 334 Japan systemic corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 335 Japan Antihistamines Pruritus Therapeutics Market, by product, 2012 - 2020 (USD
Million)
TABLE 336 Japan Antihistamines Pruritus Therapeutics Market, by product, 2021 - 2025 (USD
Million)
TABLE 337 Japan antihistamines pruritus therapeutics market, by disease type, 2012 - 2020
(USD Million)
TABLE 338 Japan antihistamines pruritus therapeutics market, by disease type, 2021 - 2025
(USD Million)
TABLE 339 Japan topical antihistamines pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
23. TABLE 340 Japan topical antihistamines pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 341 Japan systemic antihistamines pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 342 Japan systemic antihistamines pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 343 Japan local anesthetics pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 344 Japan local anesthetics pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 345 Japan counterirritants pruritus therapeutics market, by disease type 2012 - 2025
(USD Million)
TABLE 346 Japan counterirritants pruritus therapeutics market, by disease type 2012 - 2025
(USD Million)
TABLE 347 Japan immunosuppressant pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 348 Japan immunosuppressant pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 349 Japan calcineurin inhibitors pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 350 Japan calcineurin inhibitors pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 351 Japan other pruritus therapeutics market, by disease type 2012 - 2020 (USD
Million)
TABLE 352 Japan other pruritus therapeutics market, by disease type 2021 - 2025 (USD
Million)
TABLE 353 Rest of Asia Pacific pruritus therapeutics market, by product, 2012 - 2020 (USD
Million)
TABLE 354 Rest of Asia Pacific pruritus therapeutics market, by product, 2021 - 2025 (USD
Million)
TABLE 355 Rest of Asia Pacific corticosteroids pruritus therapeutics market, by product, 2012 -
2020 (USD Million)
TABLE 356 Rest of Asia Pacific corticosteroids pruritus therapeutics market, by product, 2021 -
2025 (USD Million)
TABLE 357 Rest of Asia Pacific corticosteroids pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 358 Rest of Asia Pacific corticosteroids pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
24. TABLE 359 Rest of Asia Pacific topical corticosteroids pruritus therapeutics market, by disease
type 2012 - 2020 (USD Million)
TABLE 360 Rest of Asia Pacific topical corticosteroids pruritus therapeutics market, by disease
type 2021 - 2025 (USD Million)
TABLE 361 Rest of Asia Pacific systemic corticosteroids pruritus therapeutics market, by
disease type 2012 - 2020 (USD Million)
TABLE 362 Rest of Asia Pacific systemic corticosteroids pruritus therapeutics market, by
disease type 2021 - 2025 (USD Million)
TABLE 363 Rest of Asia Pacific Antihistamines Pruritus Therapeutics Market, by product, 2012
- 2020 (USD Million)
TABLE 364 Rest of Asia Pacific Antihistamines Pruritus Therapeutics Market, by product, 2021
- 2025 (USD Million)
TABLE 365 Rest of Asia Pacific antihistamines pruritus therapeutics market, by disease type,
2012 - 2020 (USD Million)
TABLE 366 Rest of Asia Pacific antihistamines pruritus therapeutics market, by disease type,
2021 - 2025 (USD Million)
TABLE 367 Rest of Asia Pacific topical antihistamines pruritus therapeutics market, by disease
type 2012 - 2020 (USD Million)
TABLE 368 Rest of Asia Pacific topical antihistamines pruritus therapeutics market, by disease
type 2021 - 2025 (USD Million)
TABLE 369 Rest of Asia Pacific systemic antihistamines pruritus therapeutics market, by
disease type 2012 - 2020 (USD Million)
TABLE 370 Rest of Asia pacific systemic antihistamines pruritus therapeutics market, by
disease type 2021 - 2025 (USD Million)
TABLE 371 Rest of Asia Pacific local anesthetics pruritus therapeutics market, by disease type
2012 - 2020 (USD Million)
TABLE 372 Rest of Asia Pacific local anesthetics pruritus therapeutics market, by disease type
2021 - 2025 (USD Million)
TABLE 373 Rest of Asia Pacific counterirritants pruritus therapeutics market, by disease type
2012 - 2025 (USD Million)
TABLE 374 Rest of Asia Pacific counterirritants pruritus therapeutics market, by disease type
2012 - 2025 (USD Million)
TABLE 375 Rest of Asia Pacific immunosuppressant pruritus therapeutics market, by disease
type 2012 - 2020 (USD Million)
TABLE 376 Rest of Asia Pacific immunosuppressant pruritus therapeutics market, by disease
type 2021 - 2025 (USD Million)
TABLE 377 Rest of Asia Pacific calcineurin inhibitors pruritus therapeutics market, by disease
type 2012 - 2020 (USD Million)
25. TABLE 378 Rest of Asia Pacific calcineurin inhibitors pruritus therapeutics market, by disease
type 2021 - 2025 (USD Million)
TABLE 379 Rest of Asia Pacific other pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 380 Rest of Asia Pacific other pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 381 RoW pruritus therapeutics market, by product, 2012 - 2020 (USD Million)
TABLE 382 RoW pruritus therapeutics market, by product, 2021 - 2025 (USD Million)
TABLE 383 RoW corticosteroids pruritus therapeutics market, by product, 2012 - 2020 (USD
Million)
TABLE 384 RoW corticosteroids pruritus therapeutics market, by product, 2021 - 2025 (USD
Million)
TABLE 385 RoW corticosteroids pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 386 RoW corticosteroids pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 387 RoW topical corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 388 RoW topical corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 389 RoW systemic corticosteroids pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 390 RoW systemic corticosteroids pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 391 RoW Antihistamines Pruritus Therapeutics Market, by product, 2012 - 2020 (USD
Million)
TABLE 392 RoW Antihistamines Pruritus Therapeutics Market, by product, 2021 - 2025 (USD
Million)
TABLE 393 RoW antihistamines pruritus therapeutics market, by disease type, 2012 - 2020
(USD Million)
TABLE 394 RoW antihistamines pruritus therapeutics market, by disease type, 2021 - 2025
(USD Million)
TABLE 395 RoW topical antihistamines pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 396 RoW topical antihistamines pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 397 RoW systemic antihistamines pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
26. TABLE 398 RoW systemic antihistamines pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 399 RoW local anesthetics pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 400 RoW local anesthetics pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 401 RoW counterirritants pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 402 RoW counterirritants pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 403 RoW immunosuppressant pruritus therapeutics market, by disease type 2012 - 2020
(USD Million)
TABLE 404 RoW immunosuppressant pruritus therapeutics market, by disease type 2021 - 2025
(USD Million)
TABLE 405 RoW calcineurin inhibitors pruritus therapeutics market, by disease type 2012 -
2020 (USD Million)
TABLE 406 RoW calcineurin inhibitors pruritus therapeutics market, by disease type 2021 -
2025 (USD Million)
TABLE 407 RoW other pruritus therapeutics market, by disease type 2012 - 2020 (USD Million)
TABLE 408 RoW other pruritus therapeutics market, by disease type 2021 - 2025 (USD Million)
For More Information visit http://www.grandviewresearch.com/industry-analysis/pruritus-
therapeutics-market
List of Figures
FIG. 1 Pruritus therapeutics: Market segmentation
FIG. 2 Global pruritus therapeutics market, 2012 – 2025 (USD Million)
FIG. 3 Pruritus therapeutics: Market dynamics
FIG. 4 Global prevalence of atopic dermatitis, 2000 to 2025 (%)
FIG. 5 U.S. prevalence of atopic dermatitis, allergic contact dermatitis, urticaria, 2013
FIG. 6 Key opportunities prioritized
FIG. 7 Pruritus therapeutics market – Porter’s analysis
FIG. 8 Pruritus therapeutics market – PESTEL analysis
FIG. 9 Unmet needs analysis: Pruritus therapeutics market
FIG. 10 Product positioning: CT327 in psoriasis associated pruritus
FIG. 11 Prevalence of urticaria, by nature of origin (%)
FIG. 12 Pruritus therapeutics market share, by product, 2013 & 2020
28. FIG. 57 Allergic contact dermatitis market, 2012 – 2025 (USD Million)
FIG. 58 Urticaria market, 2012 – 2025 (USD Million)
FIG. 59 Other pruritic diseases market, 2012 – 2025 (USD Million)
FIG. 60 Pruritus therapeutics market share by region, 2013 & 2025
FIG. 61 North America pruritus therapeutics market, 2012 – 2025 (USD Million)
FIG. 62 Europe pruritus therapeutics market , 2012 – 2025 (USD Million)
FIG. 63 Asia Pacific pruritus therapeutics market, 2012 – 2025 (USD Million)
FIG. 64 RoW pruritus therapeutics market , 2012 – 2025 (USD Million)
Further key findings from the study suggest:
Calcineurin inhibitor is identified as the most lucrative segment of the market on account
of high usage rate of these drugs in combination therapy for the treatment of pruritus in
patients suffering from chronic pruritus and growing market penetration rates. Moreover,
the introduction of new products such as Pimecrolimus cream and Tacrolimus ointment is
expected to further drive this market.
Anti-histamines owing to its growing use as a first line treatment and presence of drugs in
pipeline with expected commercialization is also expected to grow at a healthy rate
during the forecast period.
North America led the overall market in terms of revenue in 2013 majorly on account of
the presence of high prevalence of diseases associated with pruritus, introduction of new
products targeting the unmet medical needs and growing patient awareness levels.
The Asia Pacific pruritus therapeutics market is expected to grow at a CAGR of over
5.0% during the forecast period. Presence of high unmet healthcare needs and increasing
prevalence of allergic contact dermatitis and urticaria in this region are some factors
attributing to its rapid growth rate.
Some key participants of the pruritus therapeutics market include Sanofi, Pfizer, Tai Guk
Pharmaceutical Company, Actavis, Trevi Therapeutics, Cara Therapeutics, Ocera
Therapeutics Inc. and NeRRe Therapeutics.
Manufacturers adhere to rigorous R&D in an attempt to develop cost effective products
and avoid barriers such as product recalls. In addition, this strategy is implemented
keeping the unmet needs in consideration. For Instance, Creabilis has a molecule in the
pipeline – CT327, which caters to the unmet needs associated with pruritus in patients
suffering from psoriasis.
Request free sample of this Report @ http://www.grandviewresearch.com/industry-
analysis/pruritus-therapeutics-market/request
For the purpose of this study, Grand View Research has segmented the global pruritus
therapeutics market on the basis of product, disease type and region:
29. Global Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 – 2025)
Corticosteroids
Antihistamines
Local Anesthetics
Counterirritants
Immunosuppressant
Calcineurin Inhibitors
Others
Global Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 – 2025)
Atopic Dermatitis
Allergic Contact Dermatitis
Urticaria
Others
Global Pruritus Therapeutics Regional Outlook (Revenue, USD Million, 2012 – 2025)
North America
U.S.
Rest of North America
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific
Japan
Rest of Asia Pacific
RoW
Browse All Reports of this category @
http://www.grandviewresearch.com/industry/pharmaceuticals
30. About Grand View Research
Grand View Research, Inc. is a market research and consulting company that provides off-the-
shelf, customized research reports and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and fact-based research
across a range of industries, from technology to chemicals, materials and energy. With a deep-
seated understanding of varied business environments, Grand View Research provides strategic
objective insights.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Website: Grand View Research
Blog Site: http://www.divog.org/